In Axia Growth's analysis of closed small-business sales, healthcare software businesses are grouped in the Technology sector, where businesses with under $500K of SDE sold for a median 7.4x SDE (middle half 3.5x-16.4x) across 196 sales, updated October 28, 2026. According to Capstone Partners, Healthcare IT averaged 18.8x EV/EBITDA from 2023 through YTD 2025. The two figures use different bases: Axia Growth's figure is a multiple of SDE from owner-operated small-business sales, while the Capstone Partners figure is a multiple of EBITDA from larger, often private-equity-backed deals, so the higher number is expected, not a contradiction.
Healthcare IT is in an active consolidation phase: Capstone Partners counted a record 348 sector M&A transactions in 2025 and 179 more through YTD 2026, up 22.6% year over year. Average sector multiples reached 7.3x EV/revenue for 2025 through YTD 2026, and Capstone's earlier data put the average EBITDA multiple at 18.8x for 2023 through July 2025. Large sponsors set the reference deals, including Bain Capital and Hellman & Friedman's $17 billion athenahealth buyout and Clearlake's majority investment in ModMed at a reported $5.3 billion valuation. Buyers price recurring revenue, net revenue retention, and exposure to federal interoperability rules.
Why published multiples differ
Published multiples differ mostly because they use different earnings and deal sizes. Small, owner-run businesses (under $2M of earnings) are priced on SDE, seller's discretionary earnings, which adds back the owner's pay, so SDE multiples are lower. From $2M of earnings up, buyers price on EBITDA, and multiples rise with size. Averages that mix sizes, or quote larger private-equity deals, read higher than a small-business sale.
Multiples by deal size
Sector: Technology. Median and middle half (p25-p75) of sale price to earnings.
Closed small-business sales in the Technology sector, by deal size. Axia Growth analysis of closed small-business sales, updated October 28, 2026.
Size band
n
Median multiple
p25-p75
Basis
Under $500K SDE
196
7.4x
3.5x-16.4x
SDE
$500K-$1M SDE
108
8.4x
3.9x-16.0x
SDE
$1M-$2M SDE
64
7.8x
4.4x-17.1x
SDE
$2M-$3M EBITDA
38
11.6x
6.8x-20.2x
EBITDA
$3M-$5M EBITDA
41
11.3x
6.2x-20.1x
EBITDA
$5M-$10M EBITDA
52
9.8x
7.1x-17.7x
EBITDA
$10M+ EBITDA
117
12.0x
7.6x-18.8x
EBITDA
Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of 2026-10-28. Methodology.
Every size band has a published cell for the Technology sector.
Information blocking carries real penalty exposure. OIG can impose up to a $1 million penalty per violation on an entity it finds committed information blocking. Buyers ask for complaint history, data-export practices, and API access terms.
The rules are also moving. ASTP/ONC's December 2025 HTI-5 proposal would remove 34 of 60 certification criteria and revise seven, including dropping the AI "model card" requirements. The ONC fact sheet cited here describes HTI-5 as a proposed rule.
What raises the multiple
A healthcare software business that commands a premium typically shows:
Averages hide a wide spread. Multiples come only from deals with disclosed terms, and small practice-software vendors rarely disclose them. Earnouts tied to ARR targets and seller rollover are common tools in software deals generally, but no cited source here breaks out their use for healthcare software.
Two forces will shape pricing. AI capability is now a sorting factor, as AI-enabled targets rose to 34.6% of sector deals. Federal rules may ease if HTI-5 is finalized as proposed, which would lower certification costs for developers. Vendors with high retention, current certification, and documented data-sharing practices should keep drawing the strongest bids.
In Axia Growth's analysis of closed small-business sales, healthcare software businesses are grouped in the Technology sector, where businesses with under $500K of SDE sold for a median 7.4x SDE (middle half 3.5x-16.4x) across 196 sales, updated October 28, 2026. According to Capstone Partners, Healthcare IT averaged 18.8x EV/EBITDA from 2023 through YTD 2025. The two figures use different bases: Axia Growth's figure is a multiple of SDE from owner-operated small-business sales, while the Capstone Partners figure is a multiple of EBITDA from larger, often private-equity-backed deals, so the higher number is expected, not a contradiction.
What multiple do healthcare software businesses sell for?
Axia Growth groups healthcare software businesses in the Technology sector, the closest published proxy: businesses with under $500K of SDE sold for a median 7.4x SDE across 196 sales (Axia Growth analysis of closed small-business sales, updated October 28, 2026).
SDE or EBITDA: which applies to my healthcare software business?
Axia Growth reports multiples of SDE (seller's discretionary earnings) for businesses with under $2M of earnings, where owner-operated businesses are usually priced, and multiples of EBITDA from $2M up, matching how buyers and brokers talk about deal size. For the Technology sector, Axia Growth publishes both SDE and EBITDA bands.
Who buys EHR and practice management software companies?
Large software and healthcare sponsors anchor the market, including Thoma Bravo, which closed its $1.8 billion NextGen Healthcare acquisition in 2023. Public strategics also buy. Capstone lists Roper Technologies' $1,850.0 million CentralReach deal and Waystar's Iodine Software purchase among 2025 transactions. Sources: Thoma Bravo; Capstone Partners.
Enter your industry and annual earnings in the free business value calculator for a value range drawn from the same closed-sales data. The multiples by sector page shows every published size band.
In Axia Growth's analysis of closed small-business sales, healthcare software businesses are grouped in the Technology sector, where businesses with under $500K of SDE sold for a median 7.4x SDE (middle half 3.5x-16.4x) across 196 sales, updated October 28, 2026. According to Capstone Partners, Healthcare IT averaged 18.8x EV/EBITDA from 2023 through YTD 2025. The two figures use different bases: Axia Growth's figure is a multiple of SDE from owner-operated small-business sales, while the Capstone Partners figure is a multiple of EBITDA from larger, often private-equity-backed deals, so the higher number is expected, not a contradiction. Healthcare IT logged a record 348 M&A deals in 2025 per Capstone Partners, with 7.3x average EV/revenue since 2025. Who buys EHR software and what they test.
When using information from this guide, cite Axia Growth and link to this page.
Axia Growth. Healthcare IT & Software M&A. Updated 2026-10-30. https://axiagrowth.com/resources/industries/healthcare/healthcare-it-software
For buyers
Have a mandate in Healthcare IT & Software? Share your buy box.
Axia Growth LLC provides deal origination services and is not a registered broker-dealer, investment adviser, bank, or depository institution. Where Axia's compensation is contingent on closing, it relies on the M&A broker exemption (15 U.S.C. § 78o(b)(13)) and analogous state exemptions, where available. Axia is typically engaged and paid by the acquirer, does not represent sellers, and does not provide, arrange, or receive compensation for transaction financing. See full disclaimer: /legal/disclaimer